Skip to Content

Novaccess Global Inc XSNX Stock Quote

| Rating as of


Morningstar‘s Stock Analysis XSNX

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics XSNX

Company Profile XSNX

Business Description

Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States.

8834 Mayfield Road, Suite C
Chesterland, OH, 44026
T +1 440 644-1027
Industry Biotechnology
Most Recent Earnings Jun 30, 2022
Fiscal Year End Sep 30, 2022
Employees 2